PJMHS 2021
DOI: 10.53350/pjmhs211571456
|View full text |Cite
|
Sign up to set email alerts
|

Sonographic Advancements in Characterization of Benign and Malignant Ovarian Masses

Abstract: Background: Characterization of ovarian masses is essentially required and inevitable for optimization of clinical decision making, patient care and management. The diagnosis of ovarian masses is a frequent dilemma in clinical work. Ultrasonography remains the modality of choice in the early investigation of suspected adnexal masses because of its availability and being a safe modality. Aim: To review the current literature on different patterns of manifestation of ovarian masses on ultrasound and its various … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 16 publications
0
1
0
Order By: Relevance
“…13 Ultrasound is primary imaging modality for evaluation and management of adnexal pathology having significant correlation with histological features but some of the benign lesions also have similar appearance as malignancy requiring additional work-up. [14][15] . In approximately 70% cases, ovarian malignancy does not become clinically overt until it has metastasized therefore effective detection approaches are the need of the hour.…”
Section: Discussionmentioning
confidence: 99%
“…13 Ultrasound is primary imaging modality for evaluation and management of adnexal pathology having significant correlation with histological features but some of the benign lesions also have similar appearance as malignancy requiring additional work-up. [14][15] . In approximately 70% cases, ovarian malignancy does not become clinically overt until it has metastasized therefore effective detection approaches are the need of the hour.…”
Section: Discussionmentioning
confidence: 99%